Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
"
Links to articles and other resources mentioned in Episode 57:
- The week's MS-related scientific papers, curated by MSDF
- MSDF Drug-Development Pipeline
- Timothy Vollmer MD
- Rocky Mountain MS Center
- Direct download of podcast file (beta test)
- Full Transcript
DOI:
doi/10.7493/msdf.10.27627.1